CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

Encouraging Innovation in Healthcare in a...

Duncan Turner, General Partner, SOSV, Managing...

Being a Biotech CIO, or How to...

R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA

Innovative Partnership between...

Shannon Werb, CIO, Virtual Radiologic

How to Nurture a Biotech? Sometimes, Like...

Nicholas Ventresca, SVP & CIO, ARIAD...

Formula Five for Biotech IT

Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE]

An open Innovation Approach Applied to the...

Federico Piutti, Innovation Manager, Bormioli Pharma

The Pharma Tech Landscape under the New...

Dusan Ruzic, Director, External Manufacturing, Merck

How CMOs/CDMOs can Add Value for Pharma...

Ozgur Akbulut, Director - Global Divestments and...

Encouraging Innovation in Healthcare in a...

Duncan Turner, General Partner, SOSV, Managing...

Being a Biotech CIO, or How to...

R. Mark Adams, CIO, Good Start Genetics, Cambridge, MA

Innovative Partnership between...

Shannon Werb, CIO, Virtual Radiologic

How to Nurture a Biotech? Sometimes, Like...

Nicholas Ventresca, SVP & CIO, ARIAD...

Formula Five for Biotech IT

Jeffrey Keisling, CIO & SVP, Pfizer [NYSE:PFE]

An open Innovation Approach Applied to the...

Federico Piutti, Innovation Manager, Bormioli Pharma

The Pharma Tech Landscape under the New...

Dusan Ruzic, Director, External Manufacturing, Merck

How CMOs/CDMOs can Add Value for Pharma...

Ozgur Akbulut, Director - Global Divestments and...

Roadmap for Technology Investments

Jonathan Shough, Chief Information Officer, INC Research
Tweet

Customer Focus


With increasing opportunities being pre­sented to us through our rapid IT growth, we have become better equipped to exam­ine our work processes. IT plays such an integral part of our overall work that we recognize its impact on our ability to dis­seminate information to our customers. A major focus for us has been to listen to what our customers are saying so that we can gauge exactly where our needs, solu­tions and focus should be. The ability to apply our technology solutions for each customer has resulted in more efficient clinical trials. Looking forward, we are examining how working in the cloud can help bolster an even higher level of cus­tomer delivery.


Organize Investments


Our commitment to patient safety and quality research remains of paramount importance. Making the appropriate in­vestments in technology will help to drive better integration, collaboration and au­tomation. We strive to deliver superior monitoring across all clinical operations and eliminate any complexities.


Partnering with Medidata Solutions


As a clinical research organization, our regulatory environment differs from that of other CIO’s, particularly when we part­ner with outside vendors. We have a very different set of rules under which we have to operate. As a result of our partnership with Medidata Solutions, we’ve recently had significant growth with our cloud capabilities. This part­nership resulted in INC Research becom­ing the first CRO to achieve accreditation for the Medidata Clinical Cloud in June 2013.  


Through this relationship, we can en­able a full suite of cloud-based technolo­gies in conjunction with our Trusted Pro­cess, a proprietary data-driven clinical trial management approach, allowing for greater data transparency and collabora­tion. Delivery of cost-efficient methods that optimize trials from design to data­base lock and give near real-time visibil­ity to the data that are critical to the suc­cessful running of trials.


A New Viewpoint


INC Research recognizes that analytics must be at the forefront of our operational work to enhance the decision making process. This entails disseminat­ing data to the ap­propriate people to ensure the discovery of comprehensive and accurate solu­tions.


One of the challenges, as we go global are the opportunities where redundant activities tend to creep in, it is important to eliminate those activities which are not value added


By enabling our constituents to access a single global interface, we can provide a horizontal viewpoint across the spectrum so that clinical de­cisions are better informed. This not only drives deeper analytics, it also creates a platform to make decisions more efficiently and maintain safety biometrics within clinical operations.


Globalizing Operations to Reduce Variability


Currently, the biggest IT challenge is time. From our perspective, the data we utilize may differ across regions outside of westernized culture. The obstacle here becomes how to drive high-quality ac­tionable data at the right time. This re­mains an area of focus for us to ensure we deliver services that result in high-quality data delivered at the time users require. Leveraging our Trusted Process, we make sure accurate decisions are reached local­ly, regionally and globally.


Service Provider Mod­el to Collaboration Model


As I stepped into the role of CIO, we set up a governance com­mittee to examine the business prac­tices across INC Research and to es­tablish a collaboration model to help drive technology decisions that is fully visible and inclusive. IT is now working closely with our global busi­ness leaders to work toward refining and crafting our future IT investments. We feel strongly this will result in better educated decisions regarding our technol­ogy stack and will eliminate wasted effort and duplication.


Key Listening Skills


An essential starting point to any dialogue is the ability to listen. That has been the focus of our governance committee, so we can truly comprehend where the business actually wants to go and how technol­ogy can help to generate these goals. We take time to understand the importance of the front-end operational processes and how they impact the back-end technol­ogy processes. We are currently updating and optimizing many of our technologies that will better enable us to deliver on our commitments to customers.


 


Weekly Brief

loading
Top 10 Biotech Startups in APAC - 2022
> <
  • BioTech Startups APAC 2022

    Top Vendors

    Current Issue
  • BioTech Startups APAC 2021

    Top Vendors

    Current Issue
  • BioTech Startups APAC 2022

    Top Vendors

    Current Issue
  • BioTech Startups APAC 2021

    Top Vendors

    Current Issue

Read Also

Three Steps To Succeed With Digital Transformation In Pharma?

Philippe Caby, CIO, Centrient Pharmaceuticals
Three Steps To Succeed With Digital Transformation In Pharma?

A Tale of Transformational Leadership in the IT&S Setting

Pam Banchy, CIO, VP Clinical Informatics, Western Reserve Hospital/Western Reserve Health System
A Tale of Transformational Leadership in the IT&S Setting

The CIO's Spice Rack

Praseed Thapparambil, CIO, National Assoc. of Boards of Pharmacy
The CIO's Spice Rack

Technology Enables Patient Empowerment

Technology Enables Patient Empowerment
Aligning IT with the Cadence of your Business

Aligning IT with the Cadence of your Business

William Leonard, ScD, Chief Information Officer, MPI Research
Data Governance is Relatively New to the Healthcare Industry

Data Governance is Relatively New to the Healthcare Industry

William Phillips,SVP & CIO,University Health System

DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Judy Murrah, CIO, Applied DNA Sciences Inc
DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Beyond the Pill, IT Leads the Technology Revolution at Teva Pharmaceuticals

Guy Hadari, VP & CIO, Teva Pharmaceuticals
Beyond the Pill, IT Leads the Technology Revolution at Teva Pharmaceuticals
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-startups-apac.lifesciencesreview.com/cioviewpoint/roadmap-for-technology-investments-nwid-282.html